Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7 macrophages

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2179-2188

  Khan, Salman ^a   Shin, Eun Myoung ^a   Choi, Ran Joo ^a   Jung, Yoo Hyun ^a   Kim, Jinwoong ^a   Tosun, Alev ^b   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Anomalin; Anti inflammation; NF B; Saposhnikovia divaricata; TNF

Indexed keywords

ANOMALIN; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHORUS 32; PYRANOCOUMARIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GEL MOBILITY SHIFT ASSAY; INFLAMMATION; MACROPHAGE; MALE; MOLECULAR DYNAMICS; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APIACEAE; CELL LINE; COUMARINS; CYCLOOXYGENASE 2; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II;

MURINAE; SAPOSHNIKOVIA DIVARICATA;

EID: 79960350505     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23137     Document Type: Article

References (39)

1. Aggarwal BB, Shishodia S,. 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421.
2. Ahn KS, Noh EJ, Zhao HL, Jung SH, Kang SS, Kim YS,. 2005. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of NF-κB activation in RAW 264.7 cells. Life Sci 76: 2315-2328. (Pubitemid 40313419)
3. Asahara T, Sakakibara I, Okuyama T, Shibata S,. 1984. Studies on coumarins of a Chinese drug "Qian-Hu" V. Coumarin-glycosides from "Zi-Hua Qian-Hua." Planta Med 18: 488-491.
4. Assche GV, Rutgeerts P,. 2005. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 288: 169-174.
5. Christina DC, Zuhre NT, Diana J, Kenneth LJ,. 2006. Human pregnancy safety for agents used to treat rheumatoid arthritis: Adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 8: 225.
6. Charles AD,. 2010. Anti-inflammatory agents: Present and future. Cell 140: 935-950.
7. Collins T, Cybulsky MI,. 2001. NF-κB: Pivotal mediator or innocent by stander in atherogenesis? J Clin Invest 107: 255-264. (Pubitemid 32157955)
8. Duh CY, Wang SK, Wu YC,. 1991. Cytotoxic pyranocoumarins from the aerial parts of Peucedanum japonicum. Phytochemistry 30: 2812-2814.
9. Ghosh S, Karin M,. 2002. Missing pieces in the NF-κB puzzle. Cell 109 (Suppl): S81-S96.
10. Han ZN, Boyle DL, Manning AM, Firestein GS,. 1998. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen induced arthritis. Autoimmunity 28: 197-208. (Pubitemid 29027651)
11. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF,. 1998. Activation and localization of transcription factor, NF-κB, in asthma. Am J Respir Crit Care Med 158: 1585-1592.
12. Hoffmann A, Levchenko A, Scott ML, Baltimore D,. 2002. The IκB-NF-κB signaling module: Temporal control and selective gene activation. Science 298: 1241-1245. (Pubitemid 35285493)
13. Ikeshiro Y, Mase I, Tomita Y,. 1992. Dihydropyranocoumarins from roots of Peucedanum japonicum. Phytochemistry 31: 4303-4306.
14. Kang J, Zhou L, Sun JH, Ye M, Han J, Wang BR, Guo DA,. 2008. Three new compounds from the roots of Saposhnikovia divaricata. J Asian Nat Prod Res 10: 971-976.
15. Kim SJ, Chin YW, Yoon KD, Ryu MY, Yang MH, Lee JH, Kim J,. 2008. Chemical constituents of Saposhnikovia divaricata. Korean J Pharmacog 39: 357-364.
16. Kimball SR,. 1999. Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 31: 25-29. (Pubitemid 29094786)
17. Kuo YC, Lin YL, Huang CP, Shu JW, Tsai WJ,. 2002. A tumor cell growth inhibitor from Saposhnikovae divaricata. Cancer Invest 20: 955-964.
18. Lee FS, Peters RT, Dang LC, Maniatis T,. 1998. MEKK1 activates both IκB kinase and IκB kinase b. Proc Natl Acad Sci 95: 9319-9324.
19. Lee SJ, Bai SK, Lee KS, Namkoong S, NA HJ, Ha KS,. 2003. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation. Mol Cells 16: 97-105. (Pubitemid 41582907)
20. Lee HJ, Maeng K, Dang HT, Kang GJ, Ryou CS, Jung JH, Kang HK, Prchal JT, Yoo ES,. 2011. Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by NF-κB pathway. J Mol Med 88 (89): 83-90.
21. Mark PM,. 2005. NF-κB in the survival and plasticity of neurons. Neurochem Res 30: 883-893.
22. Matthias G, Alexey K, Michael K,. 2009. Targeting innate immunity protein kinase signaling in inflammation. Nat Rev Drug Discov 8: 480-499.
23. Medzhitov R,. 2000. Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145. (Pubitemid 33741967)
24. Naureckiene S, Ajit SK, Katz AH, Sreekumar K, Rogers KE, Kennedy JD, Jones PG,. 2007. Use of a murine cell line for identification of human nitric oxide synthase inhibitors. J Pharmacol Toxicol Methods 55: 303-313. (Pubitemid 46436515)
25. Novotny NM, Markel TA, Crisostomo PR, Meldrum DR,. 2008. Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: Role of NF-κB. Cytokine 43: 215-219.
26. Sarada SS, Himadri P, Mishra C, Geetali P, Sai Ram M, Ilavazhagan G,. 2008. Role of oxidative stress and NF-κB in hypoxia induced pulmonary edema. Exp Biol Med 233: 1088-1098.
27. Shin EM, Zhou HY, Guo LY, Kim JA, Lee HL, Merfort I, Kang SS, Kim HS, Kim S, Kim YS,. 2008. Anti-inflammatory effects of glycyrol isolated from G. uralensis in LPS-induced macrophages. Int Immunopharmacol 8: 1524-1532.
28. Shyam AP, Andrew CH, Bobby YR, Pranela R,. 2009. Inflammatory mediators: Parallels between cancer biology and stem cell therapy. J Inflamm Res 2: 13-19.
29. Smolen JS, Steiner G,. 2003. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2: 473-488. (Pubitemid 37361728)
30. Soren B, Steven CLE,. 2004. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem J 382: 393-409.
31. Sun XF, Zhang H,. 2007. NF-κB and NF-κBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 22, 1387-1398. (Pubitemid 47470331)
32. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS,. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 480: 243-268. (Pubitemid 32744832)
33. Sweet MJ, Hume DA,. 1996. Endotoxin signal transduction in macrophages. J Leukoc Biol 60: 8-26. (Pubitemid 26248877)
34. Takeda K, Kaisho T, Akira S,. 2003. Toll-like receptors. Annu Rev Immunol 21: 335-376. (Pubitemid 37174535)
35. Tosun A, Bahadir O, Dinc E,. 2007. Determination of anomalin and deltoin in Seseli resinosum by LC combined with chemometric methods. Chromatographia 66: 677-683. (Pubitemid 350059767)
36. Van DB, Gijs R, Fiebo JK, Cyriel YP, Maaike MR, Guido NT, Sander JH, Van D, Maikel PP,. 2000. Expression and activation of NF-κB in the antrum of the human stomach. J Immunol 164: 3353-3359. (Pubitemid 30149001)
37. Yamamoto Y, Gaynor RB,. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 107: 135-142. (Pubitemid 32096826)
38. Yan YJ,. 1977. Preliminary experimental study on anti-convulsive Chinese herbal drugs. Chin Med J 57: 479-480.
39. Yoshikawa M, Nishida N, Ninomiya K, Ohgushi T, Kubo M, Morikawa T, Matsuda H,. 2006. Inhibitory effects of coumarinandacetylene constituents from the roots of Angelica furcijuga on D -galactosamine/LPS-induced liver injury in mice and on nitric oxide production in LPS-activated mouseperitoneal macrophages. Bioorg Med Chem 14: 456-463. (Pubitemid 41767605)